(3.15.149.45)
Users online: 12034     
Ijournet
Email id
 

Year : 2024, Volume : 16, Issue : 1
First page : ( 13) Last page : ( 22)
Print ISSN : 0975-234X. Online ISSN : 0975-4377. Published online : 2024  26.
Article DOI : 10.52711/0975-4377.2024.00003

Formulation development and evaluation of sustained release rectal suppository of domperidone maleate

Gunjal Chaitali K.1,*, Barhate Shashikant2, Bari Manoj2, Shaikh Samir2

1Shri Gulabrao Deokar Collage of Pharmacy, Jalgaon, Dist. Jalgaon

2Shri Sureshdada Jain Institute of Pharmaceutical Education and Research, Jamner, Dist. Jalgaon

*Corresponding Author E-mail: chaitaligunjal81@gmail.com

Online Published on 26 April, 2024.

Received:  29  September,  2023; :  15  November,  2023; Accepted:  23  December,  2023.

Abstract

The aim of present research was formulation development and evaluation of sustained release rectal suppository of domperidone maleate. By using Hot fusion method in that combination of PEG 4000 and poloxamer 188 was used as polymer and HPMC K4M was used for sustained released effect and surfactant was utilized for increasing bioavailability. The formulation was optimized based on Design expert software and Central Composite Design was used for study. Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) were performed to check any interaction between drug and excipients. The hardness, weight variation, friability, micro melting range test, disintegration time, dissolution studies and uniformity content of formulated batches were evaluated. All the results were within the acceptable pharmacopeial limits and were evaluated statistically by using one way ANOVA test for quadratic model. From the result, S7 batch was observed optimized formulation because upto 8 hrs 90.82% drug was released. kinetic studies of the drug release for optimized formulation follows zero order kinetics. This study was concluded that rectal route was more beneficial than oral route because it avoids first pass metabolism and enhance bioavailability of Domperidone maleate. The prepared Domperidone maleate suppository will be used for emesis caused due to chemotherapy in cancer patient and effective in the treatment of nausea and vomiting induced by drugs, migration and radiation sickness.

Top

Keywords

Domperidone maleate, PEG 4000, Poloxamer 188, Design of experiment, Sustained release, First pass effect, Hot fusion method, Rectal suppository.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
750,528,629 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.